Missing/wrong data?
Log in to edit
Dose-intensive chemotherapy including rituximab in Burkitt's leukemia or lymphoma regardless of human immunodeficiency virus infection status: final results of a phase 2 study (Burkimab).
scientific article published on 29 January 2013
Author/s
author: Josep-Maria Ribera, Albert Oriol, Mar Tormo
Work details
Publication date
January 29, 2013
-
-
Language
English
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.